These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10928519)

  • 1. The case of Abbokinase and the FDA: the events leading to the suspension of Abbokinase supplies in the United States.
    Hartnell GG; Gates J
    J Vasc Interv Radiol; 2000; 11(7):841-7. PubMed ID: 10928519
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase and the US Food and Drug Administration.
    Ouriel K
    J Vasc Surg; 1999 Nov; 30(5):957-8. PubMed ID: 10550197
    [No Abstract]   [Full Text] [Related]  

  • 3. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1999 Mar; 281(9):786. PubMed ID: 10070983
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction.
    Tranchesi B; Bellotti G; Chamone DF; Verstraete M
    Am J Cardiol; 1989 Jul; 64(3):229-32. PubMed ID: 2500842
    [No Abstract]   [Full Text] [Related]  

  • 5. Manufacturing misdeeds cost Abbott record-breaking payment.
    Lewis C
    FDA Consum; 2000; 34(3):38-9. PubMed ID: 11521253
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 7. IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval.
    Furlan AJ
    Stroke; 2006 Feb; 37(2):281. PubMed ID: 16397163
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US FDA feels the heat from Congressional hearings.
    Loewenberg S
    Lancet; 2008 May; 371(9624):1565-6. PubMed ID: 18476294
    [No Abstract]   [Full Text] [Related]  

  • 10. When EMA and FDA decisions conflict: differences in patients or in regulation?
    Wolfe SM
    BMJ; 2013 Aug; 347():f5140. PubMed ID: 23970394
    [No Abstract]   [Full Text] [Related]  

  • 11. Life-threatening hemothorax in a child following intrapleural administration of urokinase.
    Blom D; van Aalderen WM; Alders JM; Hoekstra MO
    Pediatr Pulmonol; 2000 Dec; 30(6):493. PubMed ID: 11109063
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
    Bode C; Schoenermark S; Schuler G; Zimmermann R; Schwarz F; Kuebler W
    Am J Cardiol; 1988 May; 61(13):971-4. PubMed ID: 2452564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
    Orlando VI
    Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734
    [No Abstract]   [Full Text] [Related]  

  • 14. Pro-free enterprise group challenges FDA's authority to regulate drug companies' speech.
    Skolnick AA
    JAMA; 1994 Feb; 271(5):332, 335. PubMed ID: 8283568
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparing for an FDA preapproval inspection.
    Blackmer RA
    Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 45 hospitals warehouse new drug.
    Mod Healthc; 1978 May; 8(5):28. PubMed ID: 147992
    [No Abstract]   [Full Text] [Related]  

  • 17. The outer limits of FDA inspections.
    Scarlett T
    J Parenter Sci Technol; 1991; 45(4):204-8. PubMed ID: 1770416
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases.
    Roudaut R; Lafitte S; Roudaut MF; Courtault C; Perron JM; Jaïs C; Pillois X; Coste P; DeMaria A
    J Am Coll Cardiol; 2003 Feb; 41(4):653-8. PubMed ID: 12598078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 20. US FDA's safety monitoring of drugs with expedited approval.
    Furlow B
    Lancet Oncol; 2016 Mar; 17(3):281. PubMed ID: 26831290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.